Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00649636 | Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg | PHASE1 | COMPLETED | 32 | — | — | Feb 1, 2006 | Apr 1, 2006 | Apr 24, 2024 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Fluoxetine Capsules 40 mg |
| 2 | ACTIVE_COMPARATOR | Prozac Pulvules 40 mg |
| Name | Type | Description |
|---|---|---|
| Fluoxetine Capsules 40 mg | DRUG | 40mg, single dose fasting |
| Prozac Pulvules 40 mg | DRUG | 40mg, single dose fasting |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. a. Women of childbearing potential must have negative serum beta human chorionic gonadotropin (b-HCG) pregnancy tests performed within 21 days prior to the start of the study and on the evening p...